Maximum flux with Hydrosart® membranes: Stable, hydrophilic and non-protein binding
Request information
Maximum flux with Hydrosart® membranes: Stable, hydrophilic and non-protein binding
Sartorius Stedim Biotech GmbH
All about Sartorius
More videos from Sartorius
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Last viewed contents
Hermes Pharma Ges.m.b.H. - Wien, Austria
Go to page
BioXell Announces New Members of Management Team
Go to page
Proteome Factory AG - Berlin, Germany
Go to page
Almac’s North Carolina Facility Continues Growth in Academically based Clinical Trials
Go to page
Bayer and Aventis Sign Letter of Intent on Joint Venture of Blood Plasma Business - Substantial boost planned for the Health Care business:
Go to page
Icoria, Inc. Expands Partnership with Agilent Technologies to Include $11.7 Million ATP Grant for Informatics
Go to page
Boehringer Ingelheim and AbGenomics Corporation sign worldwide exclusive collaboration and license agreement
Go to page
CellCentric Ltd. - Cambridge, United Kingdom
Go to page
Zealand Pharma A/S: Positive Phase I data for ZP1848 in Crohn’s Disease - Study findings demonstrate significant increase in citrulline levels indicating enhanced gut function
Go to page
Biovail Corporation - Mississauga, Canada
Go to page
Colorcon and BASF Announce Collaboration to Develop Film Coating Applications
Go to page
ELLERWERK GmbH & Co. KG - Hamburg, Germany
Go to page